The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Human dendritic cell subsets: an update
Open accessAbstract
Dendritic cells (DC) are a class of bone-marrow-derived cells arising from lympho-myeloid haematopoiesis that form an essential interface between the innate sensing of pathogens and the activation of adaptive immunity. This task requires a wide range of mechanisms and responses, which are divided between three major DC subsets: plasmacytoid DC (pDC), myeloid/conventional DC1 (cDC1) and myeloid/conventional DC2 (cDC2). Each DC subset develops under the control of a specific repertoire of transcription factors involving differential levels of IRF8 and IRF4 in collaboration with PU.1, ID2, E2-2, ZEB2, KLF4, IKZF1 and BATF3. DC haematopoiesis is conserved between mammalian species and is distinct from monocyte development. Although monocytes can differentiate into DC, especially during inflammation, most quiescent tissues contain significant resident populations of DC lineage cells. An extended range of surface markers facilitates the identification of specific DC subsets although it remains difficult to dissociate cDC2 from monocyte-derived DC in some settings. Recent studies based on an increasing level of resolution of phenotype and gene expression have identified pre-DC in human blood and heterogeneity among cDC2. These advances facilitate the integration of mouse and human immunology, support efforts to unravel human DC function in vivo and continue to present new translational opportunities to medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three other proteins increased in abundance in TET2-CH were CD1C (a marker of conventional dendritic cells), CLEC4C (a marker of plasmacytoid dendritic cells) and CD86 (a marker of dendritic cells, monocytes and other antigen-presenting cells)51.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“pDCs are instead characterized by a marked impairment of cytokine release in older people (27, 29).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Nomenclature of monocytes and dendritic cells in blood
Ziegler‐Heitbrock, L., Ancuța, P., Crowe, S. M., Dalod, M., Grau, V., Hart, D. N. J., Leenen, P. J. M., Liu, Y.-J., MacPherson, G. G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,229
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y.-T., Grishin, N. V., et al. (2015) · Science · doi:10.1126/science.aaa2630 · Cited by 1,927
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, É., Tussiwand, R., & Yona, S. (2014) · Nature reviews. Immunology · doi:10.1038/nri3712 · Cited by 1,923
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,734
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D., & Schmitz, J. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,433
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 998
Ravindran, A., Dasari, S., Ruan, G. J., Artymiuk, C. J., He, R. L., Viswanatha, D. S., Abeykoon, J. P., Zanwar, S., Young, J. R., Goyal, G., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100268 · Cited by 35
Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy
Lu, Y., Shi, Y., & You, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.011 · Cited by 35
Role of Dendritic Cells in Viral Brain Infections
Constant, O., Maarifi, G., Blanchet, F. P., Van de Perre, P., Simonin, Y., & Salinas, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862053 · Cited by 35
“Under specific environmental cytokine conditions, concomitantly with the expression of defined transcription factors, CMPs separate from the monocyte/macrophage axis and generate common DC progenitors (CDPs), which will give rise to pDCs and conventional DC subsets (8, 80).”
BackgroundInfluentialAiello, A., Ligotti, M. E., Garnica, M., Accardi, G., Calabrò, A., Pojero, F., Arasanz, H., Bocanegra, A., Blanco, E., Chocarro, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179880 · Cited by 37
“Plasmacytoid DCs (pDCs) produce high levels of IFN-α/β, critical for antiviral responses [57,58].”
BackgroundGhosh, S., Dutta, R., Ghatak, D., Goswami, D., & De, R. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150268 · Cited by 35
Mráz, M., Cinkajzlová, A., Kloučková, J., Lacinová, Z., Kratochvílová, H., Lipš, M., Pořízka, M., Kopecký, P., Lindner, J., Kotulák, T., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/5481725 · Cited by 34
“Dendritic cells (DCs) are professional antigen-presenting cells with the ability to suppress or instigate immune responses and to bridge innate and adaptive immunity [1].”
BackgroundThe role of antigen-presenting cells in the pathogenesis of COVID-19
Farzi, R., Aghbash, P. S., Eslami, N., Azadi, A., Shamekh, A., Hemmat, N., Entezari‐Maleki, T., & Baghi, H. B. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153848 · Cited by 33
Selenium metabolism and regulation of immune cells in immune‐associated diseases
Niu, R., Yang, Q., Dong, Y., Hou, Y., & Liu, G. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30824 · Cited by 36
“In adaptive immune, DCs can present antigens via MHC molecules to naïveT cells to stimulate their maturity (Collin & Bigley, 2018).”
BackgroundReduction of IFN-I responses by plasmacytoid dendritic cells in a longitudinal trans men cohort
Grünhagel, B., Borggrewe, M., Hagen, S. H., Ziegler, S. M., Henseling, F., Glau, L., Thiele, R.-J., Pujantell, M., Sivayoganathan, V., Padoan, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108209 · Cited by 33
Porcine Dendritic Cells and Viruses: An Update
Franzoni, G., Graham, S. P., Giudici, S. D., & Oggiano, A. (2019) · Viruses · doi:10.3390/v11050445 · Cited by 33
“They are capable of local self-renewal, but, in case of severe inflammation, LC can be generated from monocytes and other uncharacterised myeloid precursors [15,32].”
BackgroundResultInfluentialGalati, D., Zanotta, S., Capitelli, L., & Bocchino, M. (2021) · Allergy · doi:10.1111/all.15004 · Cited by 31
Plesca, I., Benešová, I., Beer, C., Sommer, U. J., Müller, L., Wehner, R., Heiduk, M., Aust, D. E., Baretton, G. B., Bachmann, M. P., et al. (2022) · Cancers · doi:10.3390/cancers14051216 · Cited by 35
“Activated cDC2s secrete large amounts of various cytokines, including tumor necrosis factor (TNF)-α, IL-1, IL-6, and IL-12 [24,25].”
BackgroundSilver, A., Feier, D., Ghosh, T., Rahman, M., Huang, J., Sarkisian, M. R., & Deleyrolle, L. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022716 · Cited by 36
Lasaviciute, G., Barz, M., van der Heiden, M., Arasa, C., Tariq, K., Quin, J. E., Farrants, A. Ö., & Sverremark‐Ekström, E. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2045046 · Cited by 32
“For instance, a subset of intestinal DCs display the ability to synthesize retinoic acid (RA) which is a multifunctional metabolite of vitamin A.(15,17,18) RA-producing DCs upregulate integrin α-chain CD103 and have a profound impact on mucosal homeostasis due to anti-inflammatory IL-10 production.”
BackgroundThe role of dendritic cells in COVID-19 infection
Wang, X., Guan, F., Miller, H. I., Byazrova, M. G., Candotti, F., Benlagha, K., Câmara, N. O. S., Lei, J., Filatov, A. V., & Liu, C. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2195019 · Cited by 34
“lung tissue: myeloid/conventional dendritic cell types 1 and 2 (referred to as cDC1 and cDC2 in mice) and plasma cell like dendritic cell (pDC) [18].”
BackgroundInfluentialRobinson, M., Glass, D. R., Durán, V., Rojas, O. L. A., Sanz, A. M., Consuegra, M., Sahoo, M. K., Hartmann, F. J., Bosse, M. M., Gélvez, R. M., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade7702 · Cited by 31
Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma
Shapiro, D. D., Dolan, B. K., Laklouk, I. A., Rassi, S., Ložar, T., Emamekhoo, H., Wentland, A. L., Lubner, M. G., & Abel, E. J. (2023) · Cancers · doi:10.3390/cancers15092500 · Cited by 35
“Dendritic cells are broadly classified into classical DCs (cDCs), which can be further categorized as cDC1 and cDC2 subtypes, plasmacytoid DCs (pDCs) and monocyte-derived inflammatory DCs (moDCs) [31].”
BackgroundWischnewski, S., Thäwel, T., Ikenaga, C., Kocharyan, A., Lerma-Martin, C., Zulji, A., Rausch, H.-W., Brenner, D., Thomas, L., Kutza, M., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00645-9 · Cited by 34
“Of note, cDC1 cells are a subpopulation of DCs playing an important role in the activation of CTLs and T H 1 cells 46,47 .”
Tian, Y., Meng, L., Wang, Y., Li, B., Yu, H., Zhou, Y., Bui, T., Abraham, C., Li, A. H., Zhang, Y., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136774 · Cited by 32
“for HLA-DR as described previously (36).”
BackgroundChen, K. L., Patel, J., Zeidi, M., Wysocka, M., Bashir, M. M., Patel, B., Maddukuri, S., White, B., & Werth, V. P. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.12.032 · Cited by 32
Nakano, R., Tran, L. M., Geller, D. A., Macedo, C., Metes, D., & Thomson, A. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705465 · Cited by 31
Inference of cell state transitions and cell fate plasticity from single-cell with MARGARET
Pandey, K., & Zafar, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac412 · Cited by 34
Anaphylatoxins spark the flame in early autoimmunity
Schanzenbacher, J., Köhl, J., & Karsten, C. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958392 · Cited by 33
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Caro, A. A., Deschoemaeker, S., Allonsius, L., Coosemans, A., & Laoui, D. (2022) · Cancers · doi:10.3390/cancers14164037 · Cited by 36
“Third, the cDC2 compartment is rather heterogenous harboring multiple sub-populations [37,39,60], which could mean that each subset may be attributed to a different functionality.”
BackgroundRighi, C., Franzoni, G., Feliziani, F., Jones, C., & Petrini, S. (2023) · Vaccines · doi:10.3390/vaccines11040785 · Cited by 33
“Plasmacytoid DCs (pDCs) are a subset of DCs that release high levels of type I IFN in response to viral infection and to TLR-9 agonists and represent the main source of type I IFN during acute foot and mouth disease virus (FMDV) [76,77].”
BackgroundInfluentialTranscriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature
Robertson, H., Li, J. S. Y., Kim, H. J., Rhodes, J. W., Harman, A. N., Patrick, E., & Rogers, N. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733231 · Cited by 31
Regulatory dendritic cells: profiling, targeting, and therapeutic application
Thomson, A. W., & Ezzelarab, M. B. (2018) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000565 · Cited by 31
“© 2018 Wolters Kluwer that differentiate from monocytes under inflammatory conditions, and nonconventional CD123þ plasmacytoid dendritic cells [5,6].”
Importance of EMT Factor ZEB1 in cDC1 “MutuDC Line” Mediated Induction of Th1 Immune Response
Smita, S., Ahad, A., Ghosh, A., Biswas, V. K., Koga, M. M., Gupta, B., Acha‐Orbea, H., & Raghav, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02604 · Cited by 31
Yashiro, T., Yamamoto, M., Araumi, S., Hara, M., Yogo, K., Uchida, K., Kasakura, K., & Nishiyama, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649572 · Cited by 31
The single‐cell transcriptional landscape of lung carcinoid tumors
Bischoff, P., Trinks, A., Wiederspahn, J., Obermayer, B., Pett, J. P., Jurmeister, P. S., Elsner, A., Dziodzio, T., Rückert, J., Neudecker, J., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33995 · Cited by 31
The Roles of Immune Cells in Gastric Cancer: Anti-Cancer or Pro-Cancer?
Sukri, A., Hanafiah, A., & Kosai, N. R. (2022) · Cancers · doi:10.3390/cancers14163922 · Cited by 32
“There are several types of dendritic cells, including myeloid dendritic cells, plasmacytoid dendritic cells, Langerhans cells, microglia cells, and CD14+ dendritic cells, which are based on the cell markers that are expressed on their surfaces [89].”
BackgroundThe Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
Goyvaerts, C., & Breckpot, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02052 · Cited by 27
Reste, M., Ajazi, K., Sayi‐Yazgan, A., Janković, R., Bufan, B., Brandau, S., Bækkevold, E. S., Petitprez, F., Lindstedt, M., Adema, G. J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1439413 · Cited by 32
“Conventional DC2 potently activate Th2, Th17 and CD4 + T cells through MHC class II (30, 32). pDCs produce large amounts of type I interferon (IFN-I), inducing antiviral immune responses (2, 31, 33 – 35).”
Levenson, D., Romero, R. J., Miller, D., Galaz, J., Garcia‐Flores, V., Neshek, B., Piqué-Regi, R., & Gomez‐Lopez, N. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.12.032 · Cited by 34
Setting the stage: The initial immune response to blood-stage parasites
Bucşan, A. N., & Williamson, K. C. (2020) · Virulence · doi:10.1080/21505594.2019.1708053 · Cited by 31
“Detailed transcriptomic profiling has expanded the classifications for the cDCs [131,133].”
BackgroundForbester, J. L., Clement, M., Wellington, D., Yeung, A. T. Y., Dimonte, S., Marsden, M., Chapman, L., Coomber, E. L., Tolley, C., Lees, E. A., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00121-20 · Cited by 30
“There are three main subsets of human DCs, pDCs and two subsets of myeloid (conventional) DCs, CD1c and CD141 , with DC hematopoiesis distinct from the development of monocytes (32).”
BackgroundEpigenetics of Dendritic Cells in Tumor Immunology
Godoy‐Tena, G., & Ballestar, E. (2022) · Cancers · doi:10.3390/cancers14051179 · Cited by 30
“1, ID2, E2-2, ZEB2, Flt3 and BATF3, which have different degrees of specificity for DCs [29,33] (see Figure 1).”
BackgroundThe immunomodulatory role of all-trans retinoic acid in tumor microenvironment
Bi, G., Liang, J., Bian, Y., Shan, G., Besskaya, V., Wang, Q., & Zhan, C. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00860-x · Cited by 32
“Therefore, currently, there is much interest in modulating DC’s function to induce efficient anti-tumor immunity, such as the administration of antigens with immunomodulators that activates endogenous DCs and the generation of DC-based vaccines [133, 134].”
BackgroundQiao, H., Mei, J., Yuan, K., Zhang, K., Zhou, F., Tang, T., & Zhao, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01536-0 · Cited by 30
“Splenic igDCs exhibit systemic immune effects, including inflammation of the ankle synovium in RA [7].”
BackgroundHeubeck, A. T., Savage, A. K., Henderson, K., Roll, C. R., Hernandez, V., Torgerson, T. R., Bumol, T. F., & Reading, J. (2022) · Cytometry Part A · doi:10.1002/cyto.a.24715 · Cited by 29
“Myeloid DCs were classified into three subsets, cross-presenting conventional cDC1 (CD141 + CD1c-), conventional cDC2 (CD141-CD1c+), and DN cDCs (CD141- CD1c-) [43, 44].”
BackgroundZhu, T., Li, Y., Wang, Y., & Li, D. (2025) · Vaccines · doi:10.3390/vaccines13040337 · Cited by 29
“Based on their function and origin, DCs are primarily categorized as classical DCs (cDCs), plasmacytoid DCs (pDCs), and monocyte-derived DCs (moDCs) [8,9].”
Iberg, C. A., & Hawiger, D. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.037 · Cited by 28
“Overall, the combination of genetic models with a targeted antigen delivery by recombinant chimeric antibodies can help clarify the specific functions of DC subsets including those applicable to human immunology [2, 7, 12, 14, 15, 54, 66, 67].”
BackgroundNie, F.-F., Ding, F., Chen, B., Shou-guo, H., Liu, Q., & Changming, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116920 · Cited by 29
Garces, S. A., Yin, C. C., Miranda, R. N., Patel, K. P., Li, S., Xu, J., Thakral, B., Poppiti, R., Medina, A. M., Sriganeshan, V., et al. (2020) · Modern Pathology · doi:10.1038/s41379-019-0440-4 · Cited by 29
“The antigenic heterogeneity of dendritic-cell populations colonizing the paracortex of skin-draining lymph nodes might reflect not only the presence of multiple distinct dendritic cell subsets, but also the varying stages of activation of these cells [5, 6, 8, 9].”
BackgroundMethodInfluentialDendritic Cells as Targets for Biomaterial-Based Immunomodulation
Eslami-Kaliji, F., Sarafbidabad, M., Rajadas, J., & Mohammadi, M. R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01987 · Cited by 29
Li, W., Morgan, R. E., Nieder, R., Truong, S., Habeebu, S. S. M., & Ahmed, A. A. (2020) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21968 · Cited by 29
Canavan, M., Marzaioli, V., Bhargava, V., Nagpal, S., Gallagher, P., Hurson, C. J., Mullan, R. H., Veale, D. J., & Fearon, U. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.745226 · Cited by 29
Garofalo, C., Marco, C. D., & Cristiani, C. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754541 · Cited by 29
Bloemendal, M., Bol, K. F., Boudewijns, S., Gorris, M. A. J., de Wilt, J. H. W., Croockewit, S., van Rossum, M. M., de Goede, A. L., Petry, K., Koornstra, R. H. T., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.2015113 · Cited by 29
Gamage, A. M., Chan, W. O. Y., Zhu, F., Lim, Y. T., Long, S., Ahn, M., Tan, C. W., Foo, R., Sia, W. R., Lim, X. F., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.008 · Cited by 30
The role of cytokines/chemokines in an aging skin immune microenvironment
Lin, Z., Hsu, C., Hwang, E., Wang, P., & Fang, J. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111761 · Cited by 30
Hussein, S. E., & Wang, W. (2023) · British Journal of Haematology · doi:10.1111/bjh.18632 · Cited by 29
“pDCs are proposed to derive from a common haematopoietic progenitor shared with myeloid DCs and monocytes.(6) The development of pDCs depends on FMSlike tyrosine kinase 3 ligand (FLT3L)(7) and master transcription factor 4 (TCF4).”
BackgroundGM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2
Lellahi, S. M., Azeem, W., Hua, Y., Gabriel, B., Rye, K. P., Reikvam, H., & Kalland, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1058963 · Cited by 29
Krupa, A., Krupa, M. M., & Pawlak, K. (2022) · Cells · doi:10.3390/cells11162604 · Cited by 31
Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy
Liu, H., Lu, Y., Zong, J., Zhang, B., Li, X., Qi, H., Yu, T., & Li, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02913-7 · Cited by 34
“Furthermore, cells resembling "MoDCs" generated during inflammation are now commonly classified as highly plastic or "non-classical" monocytes rather than true DCs [59].”
BackgroundScheffel, F., Knuschke, T., Otto, L., Kollenda, S., Sokolova, V., Cosmovici, C., Buer, J., Timm, J., Epple, M., & Westendorf, A. M. (2020) · Vaccines · doi:10.3390/vaccines8010110 · Cited by 28
“pDCs express the intracellular TLRs 7 and 9, while cDCs respond through TLRs 1-6, 8, and 10 to lipopolysaccharide, flagellin, poly(I:C), and R848 [10,11].”
BackgroundDual Pro- and Anti-Inflammatory Features of Monocyte-Derived Dendritic Cells
Azeem, W., Bakke, R. M., Appel, S., Oyan, A. M., & Kalland, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00438 · Cited by 28
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease
Kundu, D., Kennedy, L. L., Meadows, V., Baiocchi, L., Alpini, G. D., & Francis, H. (2020) · Gene Expression · doi:10.3727/105221620x15960509906371 · Cited by 28
Opejin, A., Surnov, A., Misulovin, Z., Pherson, M., Gross, C. J., Iberg, C. A., Fallahee, I., Bourque, J., Dorsett, D., & Hawiger, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108424 · Cited by 29
“cDCs are the major population among both human and murine DCs and can be further divided into the cDC1 and cDC2 subsets based on their development and expression of specific markers (Collin and Bigley, 2018; Durai and Murphy, 2016; Guilliams et al., 2016).”
BackgroundCuevas, E. S., Ouaguia, L., Mouret, S., Charles, J., de Fraipont, F., Manches, O., Valladeau‐Guilemond, J., Bendriss‐Vermare, N., Chaperot, L., & Aspord, C. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1190 · Cited by 32
“There are three functionally specialised main DC subsets in human peripheral blood and lymphoid tissues: conventional DCs (cDCs) segregated into type 2 cDCs (BDCA1/CD1c+ DCs, cDC2s) and type 1 cDCs (BDCA3/CD141 DCs, cDC1s), and plasmacytoid DCs (BDCA2 DCs, pDCs).(9,10) They differ in surface marker expression, localis…”
BackgroundCD300a and CD300f molecules regulate the function of leukocytes
Cao, Y., Ao, T., Wang, X., Wei, W., Fan, J., & Tian, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107373 · Cited by 28
Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem Cells
Satoh, T., Toledo, M. A. S., Böhnke, J., Olschok, K., Flosdorf, N., Götz, K., Küstermann, C., Sontag, S., Seré, K., Koschmieder, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667304 · Cited by 29
“DC are classified into two main subsets, classical DC (cDC) and plasmacytoid DC (pDC), based on surface marker expression, function and ontogeny, and cDC are further subdivided into cDC1 and cDC2 (Guilliams et al., 2014; Mildner and Jung, 2014; Collin and Bigley, 2018; Amon et al., 2020).”
BackgroundBarreda, D., Santiago, C. A., Rodríguez, J. R., Rodrígúez, J. F., Casasnovas, J. M., Mérida, I., & Ávila‐Flores, A. (2021) · Cells · doi:10.3390/cells10123279 · Cited by 28
“S protein and RBD promote DCs maturation as shown by enhanced expression of MHC class I and II, which is in agreement with the phenotypic profile of mDCs [3].”
ResultPlasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
Hernández, S. S., Jakobsen, M. R., & Bak, R. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911397 · Cited by 28
“, expression of CD123, CD304, IGJ, and MZB1) [4,5,25].”
BackgroundLiu, C., Zhu, J., Mi, Y., & Jin, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02663-z · Cited by 29
“Maturing DCs undergo various changes, including: (a) the processing of phagocytosis antigens; (b) the elevated presentation of antigens on MHC class I and II molecules; (c) the increased expression of critical costimulatory molecules, such as CD40, CD80, and CD86; (d) the enhanced secretion of polarizing cytokines, su…”
InfluentialLi, Q., He, J., Li, S., Tian, C., Yang, J., Yuan, H., Lu, Y. H., Fagone, P., Nicoletti, F., & Xiang, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109217 · Cited by 28
Time-Course Transcriptomic Analysis Reveals the Crucial Roles of PANoptosis in Fungal Keratitis
Xu, X., Wei, Y., Pang, J., Wei, Z., Wang, L., Chen, Q., Wang, Z., Zhang, Y., Chen, K., Peng, Y., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.6 · Cited by 27
The Cellular Composition of the Uveal Immune Environment
Reekie, I. R., Sharma, S. M., Foers, A. D., Sherlock, J. P., Coles, M. C., Dick, A. D., Denniston, A. K., & Buckley, C. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.721953 · Cited by 27
Coutant, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413670 · Cited by 27
“currently used to characterize these DC subsets, such as CD141 and C-type lectin domain family 9 (CLEC9A) for cDC1; CD1c and CLEC10A for cDC2; CD123, CD303 and CD304 for pDC; CD1c and CD163 for DC3; AXL and SIGLEC6 for transitional DC [7].”
MethodComprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
Gil-Manso, S., Blanco, I. M., López-Esteban, R., Carbonell, D., López-Fernández, L. A., West, L. J., Correa‐Rocha, R., & Pion, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793142 · Cited by 30
“Nevertheless, it was reported that precursor myeloid cells could express CD123 (28, 29).”
BackgroundInfluentialPathogenic role of monocytes/macrophages in large vessel vasculitis
Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859502 · Cited by 25
Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer
Marmonti, E., Oliva, J., & Haymaker, C. (2022) · Cells · doi:10.3390/cells11193028 · Cited by 29
How cell migration helps immune sentinels
Delgado, M., & Lennon‐Duménil, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932472 · Cited by 27
“lymphocytes and some myeloid cells (DCs and tissue-resident macrophages) exhibit an amoeboid motility (von Andrian and Mempel 2003; Lämmermann et al., 2008; Jacobelli et al., 2010; Collin and Bigley 2018).”
BackgroundCounteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber, C., Grabbe, S., & Bros, M. (2023) · Biomolecules · doi:10.3390/biom13071085 · Cited by 30
“Whereas cDCs produce IL-12 and activate helper T cells (Th)1, pDCs express surface markers of both myeloid and lymphoid origin and secrete interferon (IFN)α/β in response to (viral) infection [90,91].”
BackgroundB-cells in pulmonary arterial hypertension: friend, foe or bystander?
Sanges, S., Tian, W., Dubucquoi, S., Chang, J., Collet, A., Launay, D., & Nicolls, M. R. (2024) · European Respiratory Journal · doi:10.1183/13993003.01949-2023 · Cited by 26
“Aside from follicular dendritic cells, which operate within germinal centres in cooperation with Tfh cells, other DC subsets, such as conventional dendritic cells and monocyte-derived dendritic cells (moDCs), have been implicated in both T-cell and B-cell priming and activation [36].”
BackgroundMicrobial Symphony: Exploring the Role of the Gut in Osteoarthritis-Related Pain. A Narrative Review
Corriero, A., Giglio, M., Soloperto, R., Inchingolo, F., Varrassi, G., & Puntillo, F. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00602-9 · Cited by 28
“They link the innate and adaptive immune systems by recognizing and responding to PAMP and DAMP [43].”
BackgroundZBTB46 coordinates angiogenesis and immunity to control tumor outcome
Kabir, A. U., Zeng, C., Subramanian, M., Wu, J., Kim, M., Krchma, K., Wang, X., Halabi, C. M., Pan, H., Wickline, S. A., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01936-4 · Cited by 26
Himawan, A., Korelidou, A., Pérez‐Moreno, A. M., Paris, J. L., Domínguez‐Robles, J., Vora, L. K., Permana, A. D., Larrañeta, E., Graham, R., Scott, C. J., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02181a · Cited by 28
Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity
Anderson, J., Do, L. A. H., Wurzel, D. F., Toh, Z. Q., Mulholland, K., Pellicci, D. G., & Licciardi, P. V. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216291 · Cited by 27
Saris, A., Steuten, J., Schrijver, D. P., van Schijndel, G. M. W., Zwaginga, J. J., van Ham, S. M., & ten Brinke, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631285 · Cited by 26
“As myeloid cDC2s have an extensive array of PRRs and a widespread tissue distribution, platelet-mediated inhibition could affect immunity against a wide range of pathogens (32).”
van der Sluijs, J. V. E., van Ens, D., Thordardottir, S., Vodegel, D., Hermens, I. A. T., van der Waart, A. B., Falkenburg, J. H. F., Kester, M. G. D., de Rink, I., Heemskerk, M. H. M., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02899-3 · Cited by 27
“These CD34+ HPC-derived DC subsets were identified within total cultured cells using conventional markers: CD123+CD303+ pDCs, HLA-DR+CD1c+ cDC2s and CD141+CLEC9A+ cDC1s (Fig.”
BackgroundInfluentialBekeschus, S., Meyer, D., Arlt, K., von Woedtke, T., Miebach, L., Freund, E., & Clemen, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073790 · Cited by 26
Protective Effect of Saffron in Mouse Colitis Models Through Immune Modulation
Singh, G., Haileselassie, Y., Ji, A. R., Maecker, H. T., Sinha, S. R., Brim, H., Habtezion, A., & Ashktorab, H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07163-3 · Cited by 26
Lu, J., Sun, K., Yang, H., Fan, D., Huang, H., Hong, Y., Wu, S., Zhou, H., Fang, F., Li, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732612 · Cited by 26
Peripheral immune cells in NAFLD patients: A spyhole to disease progression
Lin, S., & Fan, J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103768 · Cited by 26
Falck‐Jones, S., Österberg, B., & Smed‐Sörensen, A. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13559 · Cited by 27
Jing, J., Zhu, C., Gong, R., Qi, X., Zhang, Y., & Zhang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114201 · Cited by 27
Hopkins, F. R., Govender, M., Svanberg, C., Nordgren, J., Waller, H., Nilsdotter‐Augustinsson, Å., Henningsson, A. J., Hagbom, M., Sjöwall, J., Nyström, S. N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1082912 · Cited by 26
James, C. A., Baer, J. M., Zou, C., Panni, U. Y., Knolhoff, B. L., Hogg, G. D., Kingston, N. L., Kang, L., Lander, V. E., Luo, J. R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0946 · Cited by 26
Wenger, M., Grosse-Kathoefer, S., Kraiem, A., Pelamatti, E., Nunes, N. N. D. S., Pointner, L., & Aglas, L. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1204025 · Cited by 31
“In vitro generated monocyte-derived dendritic cells (moDCs) are commonly used, although they do not fully resemble myeloid DCs in the blood (Collin and Bigley, 2018).”
BackgroundImpact of Plasma Membrane Domains on IgG Fc Receptor Function
Kara, S., Amon, L., Lühr, J. J., Nimmerjahn, F., Dudziak, D., & Lux, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01320 · Cited by 29
Effects of Neuropeptides on Dendritic Cells in the Pathogenesis of Psoriasis
Zhang, J., Zhao, S., Xing, X., Shang, L., Cao, J., & He, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s397079 · Cited by 25
Dantas, R. L., Freff, J., Ambrée, O., Beins, E. C., Forstner, A. J., Dannlowski, U., Baune, B. T., Scheu, S., & Alferink, J. (2021) · Cells · doi:10.3390/cells10040941 · Cited by 29
“In humans, they can be found in lymphoid tissues, lung, and peripheral blood [79].”
BackgroundInfluentialMulherkar, T., Gómez, D. J., Sandel, G., & Jain, P. (2022) · Viruses · doi:10.3390/v14092037 · Cited by 27
“Accordingly, the major subsets of DCs include myeloid/conventional DC1 (cDC1), myeloid/conventional DC2 (cDC2), and plasmacytoid DC (pDC) [11].”
BackgroundWang, L., Yang, Z., Yu, H., Lin, W., Wu, R., Yang, H., & Yang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839197 · Cited by 25
Microenvironment-responsive nanosystems for osteoarthritis therapy
Li, S., Xiong, Y., Zhu, H., Ma, T., Sun, X., & Xiao, J. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.12.002 · Cited by 27
Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature
Dhariwala, M. O., Karthikeyan, D., Vasquez, K. S., Farhat, S., Weckel, A., Taravati, K., Leitner, E. G., Clancy, S., Pauli, M. L., Piper, M. L., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100132 · Cited by 26
“21,22 25 Definitive assignment of clusters 16 and 17, which were enriched in fetal as compared to adult skin, was precluded by the absence of subset-defining markers.”
Human Peripheral Blood Dendritic Cell and T Cell Activation by Codium fragile Polysaccharide
Zhang, W., Hwang, J., Park, H., Lim, S.-M., Go, S., Kim, J., Choi, I., You, S., & Jin, J. (2020) · Marine Drugs · doi:10.3390/md18110535 · Cited by 25
“DCs are the most powerful antigen-presenting cells that induce T cell immunity [17,18].”
BackgroundBourque, J., & Hawiger, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01163 · Cited by 26
Single cell RNA-Seq reveals pre-cDCs fate determined by transcription factor combinatorial dose
Ma, W., Lee, J., Backenroth, D., Zhou, Y. J., Bush, E. C., Sims, P. A., Liu, K., & Shen, Y. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0199-y · Cited by 24
Metadata
- Authors
- Collin, M., & Bigley, V.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Collin, Matthew
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2018-02-27
- Volume
- 154
- Issue
- 1
- Pages
- 3-20
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- PMC
- PMC5904714
- OpenAlex
- W2781617771
- Cited by
- 1,301
- References
- 203
- Citations by year
- 2026: 69 · 2025: 169 · 2024: 167 · 2023: 191 · 2022: 237 · 2021: 198 · 2020: 155 · 2019: 87 · 2018: 27
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Cancer Research UK (C30484/A21025)
- Wellcome Trust (101155/Z/13/Z)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cells, dendritic cell subsets, plasmacytoid dendritic cells, myeloid dendritic cells, DC1, DC2, transcription factors, IRF8, IRF4, PU.1, monocyte-derived dendritic cells, cell surface markers, innate immunity, adaptive immunity
- MeSH terms
- Kruppel-Like Factor 4, Cell Communication, Cell Differentiation, Dendritic Cells, Humans, Immunity, Phenotype, Signal Transduction, Biomarkers, Immunophenotyping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review